Syneos Health Schedules First Quarter 2021 Earnings Call for Thursday, April 29, 2021

Rhea-AI Summary

Syneos Health (Nasdaq:SYNH) will announce its Q1 2021 financial results on April 29, 2021, before an earnings call at 8:00 a.m. ET. Interested parties can access the live webcast through the Investor Relations section of the Syneos Health website. A replay of the webcast will be available after 1:00 p.m. on the same day. Syneos Health stands out as a fully integrated biopharmaceutical solutions organization that combines a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), seeking to enhance customer performance and expedite therapy delivery.

Positive

• Syneos Health demonstrates a fully integrated biopharmaceutical solutions model.
• The company operates in over 110 countries, enhancing its market reach.

Negative

• None.

MORRISVILLE, N.C., April 01, 2021 (GLOBE NEWSWIRE) -- Syneos Health^® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its first quarter 2021 financial results on Thursday, April 29, 2021, prior to its earnings call at 8:00 a.m. ET.

Participants may access the conference call live via webcast on the Investor Relations section of the Syneos Health website at investor.syneoshealth.com. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call.

A webcast replay will be available on the Investor Relations section of the Syneos Health website at investor.syneoshealth.com after 1:00 p.m. on April 29, 2021.

About Syneos Health
Syneos Health^® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. We bring together approximately 25,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are Shortening the distance from lab to life^®, visit syneoshealth.com or subscribe to our podcast.

Investor Relations Contact: Ronnie Speight Senior Vice President, Investor Relations +1 919 745 2745 Investor.Relations@syneoshealth.com		Press/Media Contact: Gary Gatyas Executive Director, External Communications +1 908 763 3428 gary.gatyas@syneoshealth.com

FAQ

When will Syneos Health release its Q1 2021 financial results?

Syneos Health will release its Q1 2021 financial results on April 29, 2021.

What time is the Syneos Health earnings call scheduled for?

The earnings call is scheduled for 8:00 a.m. ET on April 29, 2021.

How can I access the Syneos Health earnings call?

The earnings call can be accessed via a live webcast on the Investor Relations section of the Syneos Health website.

When will a replay of the Q1 2021 earnings call be available?

A replay of the earnings call will be available after 1:00 p.m. ET on April 29, 2021.

What is Syneos Health's business model?

Syneos Health is a fully integrated biopharmaceutical solutions organization, combining a CRO and CCO to enhance customer performance.